Special Drug Use-results Survey for Long-term Use (Fostamatinib)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorKissei Pharmaceutical Co., Ltd.
About this trial
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.
Disqualifiers
None
Trial population
Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
fostamatinib
Drugoral administration
Treatment groups
149 Participants
are divided into 1 treatment groupGroup A: fostamatinib treatmented1 intervention
Trial outcomes
Primary outcomes
1
Adverse events
Time frame
18 monthsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Research siteRecruiting Tokyo and Japanese Other Cities
Japan
JapanSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov